Monday, June 18, 2018
Company News: Page (1) of 1 - 02/09/18 Email this story to a friend. email article Print this page (Article printing at page facebook
KCP Applauds Bipartisan Congressional Budget Deal Expanding Medicare Coverage Options for Dialysis Patients

(February 09, 2018)

Washington, DC, February 09, 2018 --( Kidney Care Partners (KCP) – the nation’s largest kidney coalition comprised of physician groups, providers, patient advocacy groups, manufacturers and researchers – today applauded the bipartisan Congressional budget deal that would improve and expand Medicare coverage for individuals living with kidney failure.

The deal (H.R. 1892), introduced by Senate and House leadership, includes provisions that provide thoughtful, patient-centric policies that will measurably improve access to quality care. Specifically, KCP supports the provisions that will expand the use of home dialysis therapy through use of telehealth services; expedite patient access to quality dialysis care at newly certified facilities; and extend authority for Special Needs Plans (C-SNPs) without interruption in care.

All these provisions were previously introduced in bills that passed in the House or Senate, including The Chronic Care Act (S. 870) and The Medicare Part B Improvement Act (H.R. 3178). Kidney Care Partners thanks the authors of these provisions: Sens. Orrin Hatch (R-UT), Ron Wyden (D-OR), Johnny Isakson (R-GA) and Mark Warner (D-VA) and Reps Kevin Brady (R-TX), Greg Walden (R-OR), Frank Pallone (D-NJ), and Richard Neal (D-MA).

“We commend the House and Senate for striking a deal that is good for Americans living with chronic diseases nationwide, especially those with kidney disease or kidney failure,” said KCP Chair Allen Nissenson, MD, FACP. “The Congressional Budget deal will not only improve patient choice and care coordination, but subsequently patient outcomes. This deal shows understanding and compassion for those Americans living with a chronic disease.”

Currently, 31 million Americans either have some form of kidney disease or are at risk of developing kidney failure in the future. And each year, more than 100,000 are diagnosed with End-Stage Renal Disease (ESRD) and will eventually require a kidney transplant or dialysis services.

“The House and Senate has the gratitude and support of the kidney community for making this vulnerable population a priority through previously passed legislation and this budget deal promoting quality, access and choice,” added Nissenson. “We applaud the House and Senate for approving the continuing resolution including these life-saving provisions.”

KCP is coalition of patient advocates, dialysis professionals, care providers and manufacturers dedicated to working together to improve quality of care for individuals with Chronic Kidney Disease (CKD).

Contact Information:
Kidney Care Partners
Sarah Ann Rhoades
Contact via Email

Read the full story here:

Press Release Distributed by


Page: 1

Related Keywords:Education,Online,Trade & Specialty,Medical & Health,Healthcare,Hospitals,Nursing,Specialized MedicineBusiness,Legal & Law,Government,National Government,Politics,Medical & Health,Healthcare,Managed Care & HMO,Research
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Suomen Hoivatilat Oyj: New business concepts
  • Global Cosmetic Antioxidants Market Forecast to 2023: Market is Driven by a Rise in Aging Population, Increasing Disposable Income, and Changing Lifestyle
  • Global Angiography Equipment Market, 2023 - Growing Demand for Interventional Angiography Systems in Minimally Invasive Surgeries
  • Transgender Buttock Implants and Hip Implants by Dr. Ryan Stanton Profoundly Helps Male-to-Females Add Curves to Their Buttocks and Hips to Achieve a More Curvaceous Hour-Glass Figure.
  • Medical Instruments Disinfections Market Analysis 2018 Global Opportunities, Applications, Drivers, Trends, Size, Limitations, Top Companies, Countries & Forecast 2024

  • Kanazawa University Research: Lipids and Proteins: Further Evidence for Functional Crosstalk in Cells
  • Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
  • Varian Provides Update on Proposed Sirtex Acquisition
  • WuXi STA First CDMO to Support the Approval of an Innovative Drug in China Through the "MAH" Pilot
  • Panacea Launches Medical Grade Hemp Oil Sublingual Tablet

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines